← Eichor
Study identifier: NCT04747054 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

Condition: Squamous Cell Carcinoma of Head and Neck  ·  Sponsor: UNICANCER

PhasePhase 3
Planned participants102
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Study to evaluate the efficacy of treatment by radiotherapy and pembrolizumab in newly diagnosed metastatic head \& neck cancers

This description comes directly from the study's public registry record.

Talk to the study team

NICOLAS DE SOUSA CARVALHO  ·  0171936709  ·  n-de-sousa@unicancer.fr

LAURE MONARD  ·  01 73 79 73 09  ·  l-monard@unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (26)

Institut Sainte CatherineAvignon, FranceRecruiting
CHU Jean MinjozBesançon, FranceRecruiting
CHU BordeauxBordeaux, FranceRecruiting
Institut BergoniéBordeaux, FranceRecruiting
Centre François BaclesseCaen, FranceRecruiting
CH CarcassonneCarcassonne, FranceRecruiting
Centre Jean PerrinClermont-Ferrand, FranceRecruiting
Centre Georges François LeclercDijon, FranceRecruiting
Centre Guillaume le ConquérantLe Havre, FranceSuspended
Centre Jean Bernard - Clinique Victor HugoLe Mans, FranceRecruiting
Centre Oscar LambretLille, FranceRecruiting
Groupe Hospitalier Bretagne SudLorient, FranceRecruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04747054